Table 4 Percent of motile wildtype and mutant actin–Tpm filaments determined from in vitro analysis.

From: A role for actin flexibility in thin filament-mediated contractile regulation and myopathy

Filament type

±Tpm

[Myosin] (µg ml−1)

Filaments moving (%)

n

F-Act88FWT

12.5

31.02 ± 1.64

22

F-Act88FM305L

12.5

32.57 ± 2.34

21

F-Act88FWT

+

12.5

14.96 ± 1.49

20

F-Act88FM305L

+

12.5

21.17 ± 2.11*

21

F-Act88FWT

50

68.11 ± 1.51

16

F-Act88FM305L

50

68.00 ± 2.30

20

F-Act88FWT

+

50

56.43 ± 1.04

21

F-Act88FM305L

+

50

67.81 ± 1.37#

21

F-Act88FWT

100

64.09 ± 1.64

19

F-Act88FM305L

100

67.89 ± 1.61

22

F-Act88FWT

+

100

62.87 ± 1.83

20

F-Act88FM305L

+

100

71.16 ± 1.78**

22

  1. Data are presented as mean ± SEM. *P≤0.05, **P≤0.01, #P≤0.0001 Significantly different from F-Act88FWT+Tpm. Significant differences between filament types ± Tpm at each myosin concentration were assessed using a two-way ANOVA with Bonferroni post-tests. Source data are provided as a Source Data file.